MYGN 16.69 (+2.58%)
US62855J1043• Medical Diagnostics & Research• Diagnostics & Research
Intro Stories Numbers Peers
  1. Home
  2. /
  3. All Stocks
  4. /
  5. MYGN

Myriad Genetics (MYGN) Competitor Comparison

We are evaluating the key criteria listed to compare Myriad Genetics (MYGN) against its competitors in the Diagnostics & Research industry.

Market Capitalization

28 / 58

Gross Profits

22 / 52

Total Revenue

25 / 57

EBITDA

51 / 56

Free Cashflow

42 / 56

Quick Ratio

44 / 57

Earnings per Share

43 / 56

Dividend yield

0 / 9

Total Cash

36 / 57

Performance 3 years

27 / 58

Performance 5 years

35 / 58

Performance 10 years

36 / 58

Linearity 3 years

20 / 58

Linearity 5 years

19 / 58

Linearity 10 years

15 / 58

Total Rank

23 / 58

Dividend Rank

22 / 58

Valuation Rank

28 / 58

Piotroski Rank

50 / 58

Muliplier Rank

56 / 58

Linearity 10 years - MYGN ranking 15 / 58

These are the competitors of Myriad Genetics in the industry Diagnostics & Research ranked by linearity 10 years
1. Ortho Clinical Diagnostics Holdings OCDX
33.4
2. Guardant Health GH
30.64
3. Neogen NEOG
25.64
4. Illumina ILMN
12.73
5. National Research NRC
11.68
6. Inotiv NOTV
10.28
7. Anixa Biosciences ANIX
8.54
8. Olink Holding OLK
8.11
9. Bioventus BVS
7.84
10. Fulgent Genetics FLGT
5.98
11. Global Cord Blood CO
5.67
12. DarioHealth DRIO
4.86
13. Pacific Biosciences of California PACB
4.56
14. Sera Prognostics SERA
4.13
15. Myriad Genetics MYGN
3.94
16. Syneos Health SYNH
3.71
17. Sotera Health SHC
3.66
18. Co-Diagnostics CODX
3.21
19. Qiagen QGEN
3.17
20. Enzo Biochem ENZ
3.08
21. Psychemedics PMD
2.74
22. Exact Sciences EXAS
2.61
23. Exagen XGN
2.59
24. Aspira Womens Health AWH
2.28
25. Meridian Bioscience VIVO
2.1
26. Twist Bioscience TWST
2.09
27. MDxHealth MDXH
2.09
28. MaxCyte MXCT
2.01
29. Personalis PSNL
1.95
30. Biodesix BDSX
1.93
31. bioAffinity Technologies BIAF
1.87
32. Prenetics Global PRE
1.8
33. NeoGenomics NEO
1.68
34. CareDx CDNA
1.67
35. Organovo Holdings ONVO
1.66
36. Neuronetics STIM
1.62
37. Trinity Biotech TRIB
1.58
38. Charles River Laboratories CRL
1.53
39. SeqLL SQL
1.42
40. Interpace Biosciences IDXG
1.29
41. Quest Diagnostics DGX
1.28
42. Laboratory Corp of America Holdings LH
1.18
43. PerkinElmer PKI
1.15
44. Icon ICLR
1.12
45. IQVIA Holdings IQV
1.11
46. Precipio PRPO
1.04
47. DexCom DXCM
1.01
48. Agilent Technologies A
0.91
49. Mettler-Toledo MTD
0.82
50. IDEXX Laboratories IDXX
0.78
51. Thermo Fisher Scientific TMO
0.74
52. Waters WAT
0.73
53. Danaher DHR
0.66
54. Heska HSKA
0.52
55. RadNet RDNT
0.5
56. Natera NTRA
0.45
57. Lantheus Holdings LNTH
0.33
58. Medpace Holdings MEDP
0.22
Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.